United States of America v. Eye Consultants of Pennsylvania

Harrisburg, Pennsylvania civil litigation lawyer represented the Defendant charged with Qui Tam fraud.



Between September 1, 2018, and April 7, 2025, ECOP submitted claims to Medicare Part B for E&M services on the same date of service for beneficiaries receiving bilateral eye injections in violation of the applicable Medicare rules and regulations.



"The United States Attorney's Office in the Middle District of Pennsylvania is dedicated to working with its law enforcement partners to zealously investigate allegations of the submission of unsupported claims to federal healthcare programs,” said Acting United States Attorney John C. Gurganus. "Improperly billing federal healthcare programs increases the costs of these taxpayer-funded programs. Settlements like this one are an important part of the fight against fraud, waste and abuse.”



"Providers who participate in the Medicare program must abide by the program's rules when submitting claims,” said Maureen Dixon, Special Agent in Charge of the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG). "HHS-OIG is committed to protecting the integrity of the Medicare program and maintaining the trust of the people it serves. We will continue to work with the United States Attorney's Office and other law enforcement partners to address allegations brought under the False Claims Act.”



This matter was handled by the Department of Health and Human Services, Office of Inspector General (HHS-OIG), and Assistant U.S. Attorney Tamara Haken of the Affirmative Civil Enforcement Unit of the U.S. Attorney's Office for the Middle District of Pennsylvania.

Eye Consultants of Pennsylvania, PC (ECOP) agreed to pay $790,000.00 to resolve False Claims Act allegations of civil liability for submitting claims to Medicare for Evaluation & Management (E&M) services that violated Medicare rules and regulations.